CVR: 39859211
Previous names: PrOxi Biotech IVS, PrOxi Biotech ApS
Proxi Biotech ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named PrOxi Biotech ApS and PrOxi Biotech IVS. The management consists of Rene Jørgensen and Aria Aminzadeh. The company is owned by Aminzadeh Holding ApS, Dr RJ Holding ApS and Century House Holding ApS. In 2025, the company reported a gross profit of DKK -430,820 and a net result of DKK -1,688,504 compared with DKK 426,762 the year before. Equity amounted to DKK -1,712,625.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er at udøve forskning og eksperimentel udvikling indenfor bioteknologi
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationCompared to 1.052 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Proxi Biotech ApS has published its annual report for 2025. Gross profit came to DKK -430,820, and the net result was DKK -1,688,504.
Contact info changed: new phone: 22552202, new email: [email protected], new website: www.proxibiotech.com (April 14, 2026).
As of December 19, 2025, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Proxi Biotech ApS.
As of December 19, 2025, Grant Thornton, Godkendt Revisionspartnerselskab has stepped down as auditor of Proxi Biotech ApS.
As of November 10, 2025, Per Bo Pedersen Fischer has joined the board of directors of Proxi Biotech ApS.
As of November 10, 2025, Rene Jørgensen has joined the board of directors of Proxi Biotech ApS.
As of November 10, 2025, Sten Verland has joined the board of directors of Proxi Biotech ApS.
As of November 10, 2025, Aria Aminzadeh has joined the board of directors of Proxi Biotech ApS.
As of November 10, 2025, Paul Jefferson Hargreaves has joined the board of directors of Proxi Biotech ApS.
Proxi Biotech ApS has published its annual report for 2024. Gross profit came to DKK 983,921, and the net result was DKK 426,762.
As of April 9, 2025, Grant Thornton, Godkendt Revisionspartnerselskab has been appointed auditor of Proxi Biotech ApS.
As of April 9, 2025, JS Revision, Godkendt Revisionsaktieselskab has stepped down as auditor of Proxi Biotech ApS.
On January 22, 2025, the company changed its name from PrOxi Biotech ApS to Proxi Biotech ApS.
As of January 22, 2025, Dr RJ Holding ApS is registered as an owner of Proxi Biotech ApS with an ownership share of 33%.
As of January 22, 2025, Century House Holding ApS is registered as an owner of Proxi Biotech ApS.
As of January 7, 2025, Aminzadeh Holding ApS is registered as an owner of Proxi Biotech ApS with an ownership share of 33%.
Proxi Biotech ApS has published its annual report for 2023. Gross profit came to DKK 520,824, and the net result was DKK 68,661.
Proxi Biotech ApS has published its annual report for 2022. Gross profit came to DKK 411,123, and the net result was DKK -72,371.
Proxi Biotech ApS has published its annual report for 2021. Gross profit came to DKK 460,613, and the net result was DKK 2,349.
Proxi Biotech ApS has published its annual report for 2020. Gross profit came to DKK 336,912, and the net result was DKK 84,946.
As of November 29, 2020, Kasper Gubba Ørtenblad has stepped down as director of Proxi Biotech ApS.
As of June 10, 2020, Rene Jørgensen is registered as adm. dir. of Proxi Biotech ApS.
As of June 10, 2020, Kasper Gubba Ørtenblad is registered as director of Proxi Biotech ApS.
As of June 9, 2020, Rene Jørgensen has stepped down as director of Proxi Biotech ApS.
As of June 9, 2020, Kasper Gubba Ørtenblad has stepped down as adm. dir. of Proxi Biotech ApS.
Proxi Biotech ApS has published its annual report for 2019. Gross profit came to DKK 176,379, and the net result was DKK -93,581.
As of May 6, 2020, Rene Jørgensen is registered as director of Proxi Biotech ApS.
As of May 6, 2020, Aria Aminzadeh is registered as director of Proxi Biotech ApS.
As of April 15, 2020, JS Revision, Godkendt Revisionsaktieselskab has been appointed auditor of Proxi Biotech ApS.
As of April 15, 2020, Revisionshuset Tal & Tanker Statsautoriseret Revisionspartnerselskab has stepped down as auditor of Proxi Biotech ApS.
As of November 10, 2019, Revisionshuset Tal & Tanker Statsautoriseret Revisionspartnerselskab has been appointed auditor of Proxi Biotech ApS.
On November 10, 2019, the company changed its name from PrOxi Biotech IVS to PrOxi Biotech ApS.
Proxi Biotech ApS has published its interim report for the period September 13, 2018 – December 31, 2018.
As of September 13, 2018, Kasper Gubba Ørtenblad is registered as adm. dir. of Proxi Biotech ApS.
Proxi Biotech ApS was founded on September 13, 2018.
Companies in the same industry and area
CVR 45950263
CVR 31888263
CVR 34878366
CVR 34896828
CVR 35249389
companydata.dk